Eliverta Liska
Psychiatric/Mental Health · Fremont, OHNPI 1336878206
Payments from drug & device makers
Across 171 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$979
- AbbVie$830
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$372
- Johnson & Johnson$370
- Alkermes, Inc.$206
- Otsuka America Pharmaceutical, Inc.$187
- plus $597 from 13 others
What the payments were for
- Food & beverage$3,09187%
- Education$43612%
- Other$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 46 | $979 |
| AbbVie | 41 | $830 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $372 |
| Johnson & Johnson | 15 | $370 |
| Alkermes, Inc. | 6 | $206 |
| Otsuka America Pharmaceutical, Inc. | 11 | $187 |
| Neurocrine Biosciences, Inc. | 11 | $179 |
| Vanda Pharmaceuticals Inc. | 5 | $94 |
| Indivior Inc. | 3 | $74 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Lundbeck LLC | 2 | $46 |
| Braeburn Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $22 |
| Corium, LLC | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Baxter Healthcare | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$480
- Austedo XR$124
- ARISTADA INITIO$120
- UZEDY$113
How this compares
$3,541 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 43 | $4,127 |
| Buspirone Hcl | 51 | $1,143 |
| Sertraline Hcl | 44 | $450 |
| Lamotrigine | 25 | $267 |
| Hydroxyzine Pamoate | 30 | $196 |
| Duloxetine Hcl | 18 | $183 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $103 |
| Prazosin Hcl | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Fremont
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.